The Neuromuscular Disease Network for Canada

funder-logos_nmd4c

Upcoming webinar: Genomics 101

The Neuromuscular Disease Network for Canada (NMD4C) and Muscular Dystrophy Canada (MDC) are pleased to invite you to a webinar about genomics. This webinar is primarily targeted at Canadian clinicians, academics and trainees with an interest in neuromuscular disease. NMD4C and MDC are providing organisational and technical support, and this is an independent clinical/academic webinar with no industry sponsorship.

This webinar is CME-accredited. The NMD Rounds & Educational Webinars is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

If you have any questions, please email


Register HERE


Topics and speakers:

Introduction

Dr. James Dowling (NMD4C Steering Committee Member)

Genetic counselling: What do families need to know and when?

Lauren Brady

Testing platforms

Kim Amburgey (NMD4C Collaborator)

Non-genetic diagnostics in the genomics era

Dr. Hernan Gonorazky

Variants of unknown significance

Dr. James Dowling (NMD4C Steering Committee Member)


Learning objectives:

  1. Compare different genetic technologies and select the best test for your patient
  2. Gain a better understanding of result interpretation and variants of unknown significance
  3. Recognize opportunities for implementing genetic counselling into patient care
  4. Identify the appropriate use of non-genetic diagnostics tests in the genomic era
file

Read next...

JND-cover

Latest edition of the Journal of Neuromuscular Diseases now online – Sep 2020

A new issue of the Journal of Neuromuscular Diseases has recently been released: Volume 7, Issue 4 (Sep 2020)

Clinical-Guidelines-Register-Now-1200x1200

CME-accredited webinar | Interdisciplinary guidelines for myotonic dystrophy type 1 (DM1) management across the spectrum

NMD4C and MDC are pleased to invite you to a CME-accredited webinar on interdisciplinary guidelines for myotonic dystrophy type 1 (DM1).

stacey

NMD4C steering committee member Stacey Lintern appointed CEO of Muscular Dystrophy Canada

We are happy to congratulate our steering committee member Stacey Lintern for her recent appointment as CEO of our partner organization Muscular Dystrophy Canada (MDC)!

WMS-Challenge-Facebook-1200x1200-white-teal (1)

World Muscle Society “25 Challenge” to support Muscular Dystrophy Canada

Many neuromuscular specialists and members of multidisciplinary neuromuscular teams in Canada are part of the World Muscle Society (WMS). Because people living with neuromuscular conditions have been hit particularly hard by the COVID-19 pandemic, WMS has asked all WMS2020 Congress attendees to get involved by taking on their very own WMS25 Challenge to raise money and awareness for relevant charities across the world. Muscular Dystrophy Canada (MDC), a funder and partner of NMD4C, has been selected as the neuromuscular organization of choice for Canada.

Screenshot 2020-09-11 094906

Upcoming webinar: SMA Academy – Hot Topics in Basic SMA Research

NMD4C and Biogen are pleased to invite you to our SMA Academy session – Hot Topics in Basic SMA Research on Tuesday Sept. 22 at 5:00pm.

email-3249062_1280

September 2020 newsletter

Topics include Muscular Dystrophy Awareness Month, our new blog featuring NMD4C’s early career members, our recent advocacy work, recent and upcoming webinars, new research from NMD4C participants, and a member spotlight on steering committee member Dr. Rashmi Kothary.